APA (7th ed.) Citation

Shytaj, I. L., Fares, M., Gallucci, L., Lucic, B., Tolba, M. M., Zimmermann, L., . . . Lusic, M. (2022). The FDA-approved drug cobicistat synergizes with remdesivir to inhibit SARS-CoV-2 replication in vitro and decreases viral titers and disease progression in Syrian hamsters. mBio, 13(2), . https://doi.org/10.1128/mbio.03705-21

Chicago Style (17th ed.) Citation

Shytaj, Iart Luca, et al. "The FDA-approved Drug Cobicistat Synergizes with Remdesivir to Inhibit SARS-CoV-2 Replication in Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters." MBio 13, no. 2 (2022). https://doi.org/10.1128/mbio.03705-21.

MLA (9th ed.) Citation

Shytaj, Iart Luca, et al. "The FDA-approved Drug Cobicistat Synergizes with Remdesivir to Inhibit SARS-CoV-2 Replication in Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters." MBio, vol. 13, no. 2, 2022, https://doi.org/10.1128/mbio.03705-21.